RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 16, 16:00
RVL Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 38.59M |
May 16, 2024 | 38.59M |
May 15, 2024 | 38.59M |
May 14, 2024 | 38.59M |
May 13, 2024 | 38.59M |
May 10, 2024 | 38.59M |
May 09, 2024 | 38.64M |
May 08, 2024 | 38.64M |
May 07, 2024 | 38.64M |
May 06, 2024 | 38.64M |
May 03, 2024 | 38.64M |
May 02, 2024 | 38.60M |
May 01, 2024 | 38.59M |
April 30, 2024 | 38.59M |
April 29, 2024 | 38.59M |
April 26, 2024 | 38.59M |
April 25, 2024 | 38.59M |
April 24, 2024 | 38.59M |
April 23, 2024 | 38.59M |
April 22, 2024 | 38.59M |
April 19, 2024 | 38.59M |
April 18, 2024 | 38.59M |
April 17, 2024 | 38.59M |
April 16, 2024 | 38.59M |
April 15, 2024 | 38.59M |
Date | Value |
---|---|
April 12, 2024 | 38.59M |
April 11, 2024 | 38.59M |
April 10, 2024 | 38.59M |
April 09, 2024 | 38.60M |
April 08, 2024 | 38.60M |
April 05, 2024 | 38.60M |
April 04, 2024 | 38.60M |
April 03, 2024 | 38.60M |
April 02, 2024 | 38.60M |
April 01, 2024 | 38.60M |
March 28, 2024 | 38.60M |
March 27, 2024 | 38.60M |
March 26, 2024 | 38.60M |
March 25, 2024 | 38.60M |
March 22, 2024 | 38.59M |
March 21, 2024 | 38.60M |
March 20, 2024 | 38.60M |
March 19, 2024 | 38.60M |
March 18, 2024 | 38.60M |
March 15, 2024 | 38.60M |
March 14, 2024 | 38.60M |
March 13, 2024 | 38.60M |
March 12, 2024 | 38.60M |
March 11, 2024 | 38.60M |
March 08, 2024 | 38.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.59M
Minimum
Mar 22 2024
643.48M
Maximum
Jul 10 2020
251.58M
Average
219.24M
Median
Oct 06 2022
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 5.156M |
Palatin Technologies Inc | 22.26M |
iBio Inc | 16.77M |
Theriva Biologics Inc | -8.901M |
Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -23.89M |
Revenue (Quarterly) | 8.258M |
Total Expenses (Quarterly) | 16.38M |
EPS Diluted (Quarterly) | -0.24 |
Gross Profit Margin (Quarterly) | 76.44% |
Profit Margin (Quarterly) | -289.3% |